{"nct_id":"NCT03029780","title":"An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2017-02-16","start_date_type":"ACTUAL","primary_completion_date":"2017-11-27","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}